EAST LANSING - Could cannabis compounds slow the progress of degenerative brain diseases like Alzheimer's and Parkinson's?
Norbert Kaminski, a professor of pharmacology and toxicology at Michigan State University, thinks its possible, and he's determined to find out.
Kaminski has studied the compounds of cannabis, otherwise known as marijuana, since 1990, looking at their effects on the immune system and whether they have therapeutic applications. That work has received continuous funding from the National Institute of Health since 1992.
Some compounds have known anti-inflammatory properties, Kaminski said, which prompted him to look at applications for degenerative brain diseases. He's most interested in molecules that, "may be able to act as anti-inflammatory agents but do not possess psychotropic effects."
Top Image: © Konstiantyn Zapylaie | Adobe Stock
